Abstract
Natural microcin J25 (MccJ25) represent promising alternatives to traditional antibiotics for the treatment of drug-resistant infections. However, little is known about the antibacterial activity of recombinant MccJ25 against foodborne pathogens. Here, the activity of recombinant MccJ25 was examined using a matrix of conditions in order to assess the efficacy of recombinant MccJ25 as a mitigation against foodborne pathogens, such as Salmonella species and Escherichia coli (E. coli) O157:H7. Results showed that recombinant MccJ25 displayed excellent antimicrobial activity against these foodborne pathogens, including clinical isolates of Salmonella and E. coli, as well as clinical antibiotic-resistant Salmonella and E. coli isolates with different minimal inhibitory concentrations. In addition, antimicrobial activity curves and Live/Dead assay evidenced that recombinant MccJ25 harbors strong bactericidal activity against Salmonella and E. coli O157:H7. Notably, recombinant MccJ25 also had great potency and induced fast mortality against different growth phase of Salmonella and E. coli. The stability analysis results showed that the activity of recombinant MccJ25 was not influenced by temperatures as high as 121°C. Varying the pH from 2.0 to 9.0 did not appear to affect the activity of recombinant MccJ25. Under the challenge of several proteases, simulated gastrointestinal fluids and serum, recombinant MccJ25 still maintained exceptionally strong antimicrobial activity. Significant reductions in Salmonella Pullorum levels were also achieved in food biological environments, such as milk, egg and meat. Moreover, we demonstrated that recombinant MccJ25 appeared to act by inducing membrane breaks, thinning, and disintegration in the Salmonella Pullorum cytoplasmic membrane. Taken together, these results indicated that recombinant MccJ25 could be an effective alternative for mitigating and prevention of Salmonella and E. coli infection in food, animal and agriculture applications.
Highlights
The most notorious and common pathogenic Escherichia coli (E. coli) O157:H7, Salmonella Typhimurium and Salmonella Pullorum strains are primary enteric pathogens that inhibit human and animal health and cause food poisoning and food-related epidemics around the world (Sable et al, 2000; Ma et al, 2016; Fan et al, 2017)
Recombinant antimicrobial peptides (AMPs) is promising alternatives to conventional antibiotics for the treatment of pathogens infections because of chemical synthesis is not suited for synthesis of large AMPs and is not scalable for large-scale production for clinical studies and commercial use (Cao et al, 2018; Wei et al, 2018; Kim et al, 2019; Meng et al, 2019)
The effects of recombinant microcin J25 (MccJ25) on survival and growth of Salmonella and E. coli in different environments were examined in order to ascertain its potential as a antimicrobial agent for various domains applications
Summary
The most notorious and common pathogenic Escherichia coli (E. coli) O157:H7, Salmonella Typhimurium and Salmonella Pullorum strains are primary enteric pathogens that inhibit human and animal health and cause food poisoning and food-related epidemics around the world (Sable et al, 2000; Ma et al, 2016; Fan et al, 2017). Fresh produce, such as milk, meat, and egg, is increasingly related to the incidence of foodborne illness, and outbreaks associated with fresh produce consumption by human or animals have risen substantially recently (Centers for Disease Control and Prevention [CDC], 2010, 2013). There is an urgent need to encourage the produce industry to find more efficient and less toxic antimicrobial agents alternatives for treating bacterial infections, those caused by foodborne pathogens, and to ensure human health, food safety, and animal health
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
